Cargando…
RNA‐binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression
The androgen receptor (AR) pathway is critical for prostate cancer carcinogenesis and development; however, after 18‐24 months of AR blocking therapy, patients invariably progress to castration‐resistant prostate cancer (CRPC), which remains an urgent problem to be solved. Therefore, finding key mol...
Autores principales: | Zhao, Jing, Zhang, Yu, Liu, Xi‐sheng, Zhu, Fang‐ming, Xie, Feng, Jiang, Chen‐yi, Zhang, Zi‐ye, Gao, Ying‐li, Wang, Yong‐chuan, Li, Bin, Xia, Shu‐jie, Han, Bang‐min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004550/ https://www.ncbi.nlm.nih.gov/pubmed/31833612 http://dx.doi.org/10.1111/cas.14280 |
Ejemplares similares
-
Tau oligomers mediate aggregation of RNA‐binding proteins Musashi1 and Musashi2 inducing Lamin alteration
por: Montalbano, Mauro, et al.
Publicado: (2019) -
Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT
por: Sun, Jian, et al.
Publicado: (2021) -
RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival
por: Fujiwara, T, et al.
Publicado: (2016) -
Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein
por: Sheng, Weiwei, et al.
Publicado: (2016) -
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
por: Erazo, Tatiana, et al.
Publicado: (2022)